PCM
GH icon

Penserra Capital Management’s Guardant Health GH Stock Holding History

Penserra Capital Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
+19,575
New +$2.13M 0.02% 322
2026
Q1 		– Sell
-15,720
Closed -$1.6M – 1133
2025
Q4 		$1.6M Buy
+15,720
New +$1.41M 0.02% 349
2025
Q2 		– Sell
-52,293
Closed -$2.23M – 1069
2025
Q1 		$2.23M Buy
+52,293
New +$2.26M 0.04% 289

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Penserra Capital Management's GH Position: Q2 2026 in Review

Penserra Capital Management opened a new position in Guardant Health (GH) in Q2 2026: 19,575 shares worth $2.94M. The stake represents 0.02% of the portfolio and ranks #322 among its holdings. This is a return to the name: Penserra Capital Management previously reported a position in GH as recently as Q4 2025.

Penserra Capital Management first reported a position in GH in Q1 2025 and has held it in 3 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Penserra Capital Management held 19,575 shares of Guardant Health worth $2.94M as of Q2 2026.
  • Guardant Health was a new Penserra Capital Management position in Q2 2026.
  • Guardant Health made up 0.02% of Penserra Capital Management's portfolio in Q2 2026, its #322 holding.
  • Penserra Capital Management first reported a position in Guardant Health in Q1 2025 and has held it in 3 quarters since.
  • 600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.